11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
As MD and IVD regulations evolve in Europe, you need the right partner to guide your planning and decision-making to successfully certify your device. Veristat’s team of highly dedicated and experienced regulatory professionals provides impactful strategic regulatory and operational support on both a full-service or functional service basis, including technical documentation development, CER/PER, statistical support, and data management for your MD clinical investigations and IVD performance studies.
We ensure the fulfillment of every aspect of your regulatory requirements, from strategy-setting to submissions and approvals and post-approval maintenance.
Veristat team members Darren Taylor Senior Business Development Director and Andrea Larrañaga Associate Manager, Regulatory Affairs, will be at the venue— ready to listen to your needs and share Veristat’s expertise.
https://www.veristat.com/regulatory-medical-device-ivd
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes. .

Website: Medtech Forum EU
11 min read
Jul 7, 2026 Veristat Blog
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
2 min read
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...